期刊档案 · INFECTIOUS DISEASES-PHARMACOLOGY & PHARMACY

Journal of Infection and Chemotherapy

ISSN 1341-321X · eISSN 1437-7780 · Springer Japan · JAPAN · Bimonthly · 创刊 1995

Journal of Infection and Chemotherapy 中科院 医学 4区(2025 年升级版),影响因子 1.67,混合开放获取,APC 约 2,650 美元,近 24 个月 112 篇文章投稿到接收中位 91 天,官网公布录用率 21%,2025 年发文 279 篇,SCIE、Scopus 收录。

影响因子1.67LetPub 汇总的最新公布值
中科院分区医学 4区2025 年升级版大类 · 2026 新锐版 医学 4区
审稿周期91 天投稿到接收中位数 · 近 24 个月 112 篇文章 · PubMed
版面费2,650 USD混合期刊,仅开放获取发表时收取
录用比例21%期刊官网公布
年发文量279 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Journal of Infection and Chemotherapy 由 Springer Japan 出版,属中科院医学大类(2025 升级版4区)。按 OpenAlex 近年发文统计,该刊主要发表 Pneumonia and Respiratory Infections、Antibiotic Resistance in Bacteria、Antimicrobial Resistance in Staphylococcus 等主题的论文,这 3 个主题约占 25.3%,主导子领域为 Epidemiology。(根据 OpenAlex 主题统计与中科院分区数据生成)

The Journal of Infection and Chemotherapy (JIC) - official journal of the Japanese Society of Chemotherapy, The Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control - welcomes original papers, review papers, laboratory or clinical, as well as case reports, notes, committee reports, surveillance and guidelines from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection. Experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials are particularly welcome.

摘自期刊官网 Aims & Scope

研究方向(LetPub):INFECTIOUS DISEASES-PHARMACOLOGY & PHARMACY

主编 Koichi Izumikawa Nagasaki出版商官网

编委会国家分布:未见中国大陆编委;主要国家 日本 74(共 74 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Pneumonia and Respiratory InfectionsMedicine8.9%
  2. Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology8.8%
  3. Antimicrobial Resistance in StaphylococcusMedicine7.7%
  4. Antibiotics Pharmacokinetics and EfficacyMedicine6.8%
  5. Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology5.9%
  6. Streptococcal Infections and TreatmentsMedicine5.2%
  7. Antifungal resistance and susceptibilityMedicine4.7%
  8. Respiratory viral infections researchMedicine3.9%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)医学 4 区
类别学科分区
大类医学4 区
小类传染病学INFECTIOUS DISEASES4 区
小类药学PHARMACOLOGY & PHARMACY4 区

Top 期刊:否综述期刊:否

《新锐期刊分区表》( 2026年3月发布)医学 4 区
类别学科分区
大类医学4 区
小类传染病学INFECTIOUS DISEASES4 区
小类药学PHARMACOLOGY & PHARMACY4 区

Top 期刊:否综述期刊:未标注

期刊分区表( 2023年12月旧的升级版)医学 4 区
类别学科分区
大类医学4 区
小类传染病学INFECTIOUS DISEASES4 区
小类药学PHARMACOLOGY & PHARMACY4 区

Top 期刊:否综述期刊:否

数据库收录

SCIEScopusLetPub

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

PubMed出版商官网

其他:Crossref

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子
1.67LetPub ·
影响因子(出版商公布)
1.7出版商官网 ·
CiteScore 2026-06
3.1LetPub ·
CiteScore(出版商公布)
3.1出版商官网 ·
SJR 2026-06
0.5LetPub ·
SNIP 2026-06
0.66LetPub ·
h-index
53LetPub ·
h-index
86OpenAlex ·
i10-index
1,974OpenAlex ·
两年平均被引
1.71OpenAlex ·
自引率
5.9%LetPub ·
Gold OA 文章占比
11.06%LetPub ·

发文规模

年文章数
420LetPub ·

逐年发文量 OpenAlex 统计 · 累计 4,617 篇 · 当年数据不完整

年份发文量其中 OA被引
20261834138
202527999423
2024277125806
20232551391,259
20222891812,336
20212971633,173

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

文章统计的审稿周期 PubMed 登记的稿件日期 · 至

91 天投稿到接收中位数 · P25–P75 67 天 – 115 天

接收到上线
中位数 2 天(112 篇)
投稿到上线
中位数 94 天
样本
112 篇有投稿与接收日期的文章(窗口内共 658 篇),最近一篇接收于

只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。

其他来源

平均审稿速度(社区反馈)
一般,3-8周LetPub ·
录用率(出版商公布)
21%出版商官网 ·
外审后首次决定
32 天出版商官网 ·
投稿到接收
88 天出版商官网 ·
接收到发表
1 天出版商官网 ·
评审方式
单盲同行评审出版商官网

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

混合开放获取LetPub

订阅期刊,作者可付费选择开放获取发表。

来源文章处理费费用减免许可证观测时间
OpenAlexUSD 2,650 / EUR 2,480 / GBP 2,120 / JPY 328,680——
出版商官网USD 3,000——

混合期刊的文章处理费仅在作者选择开放获取发表时收取;按订阅方式发表通常不收费。

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

接收的文章类型9 种,含篇幅限制
  1. case reportOriginal articleOriginal articles should be concise. Papers giving minimum inhibitory concentration (MIC) values of drugs without supporting clinical observatio…未说明篇幅
  2. committee reportCommittee reports from any organization concerned with medical practice or research in the fields of infection and chemotherapy will be considered for publicati…未说明篇幅
  3. editorialEditorials are considered for publication by invitation.未说明篇幅
  4. guidelineGuidelines for medical practice, clinical examinations, or experiments in the fields of infection and chemotherapy will be considered for publication. Abstract …未说明篇幅
  5. letterOriginal articleOriginal articles should be concise. Papers giving minimum inhibitory concentration (MIC) values of drugs without supporting clinical observatio…未说明篇幅
  6. letter to the editorQuestions or comments concerning recently published papers should be sent to the Editor, who will refer them to the authors. The questions and authors' replies …未说明篇幅
  7. noteNotes should be concise reports. The length of the text is less than 1800 words excluding Abstract, Acknowledgement and COI description. Tables and/or figures s…未说明篇幅
  8. reviewOriginal articleOriginal articles should be concise. Papers giving minimum inhibitory concentration (MIC) values of drugs without supporting clinical observatio…未说明篇幅
  9. review articlethan 250 words. Keywords are required. Review article The length of the text is from 2500 to 5000 words excluding Acknowledgement and COI description. Abstract …正文 ≤ 5,000 词
出版商官网
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、许可与版权、开放获取、同行评审、预印本
AI 使用 Declaration of generative AI in scientific writing

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

原文 ↗出版商官网 ·
作者资格 Authorship

Keywords: Immediately after the abstract, provide 3-6 keywords, using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, "and", "of", etc.). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywor 模型摘要

All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.

原文 ↗出版商官网 ·
利益冲突 Declaration of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…

原文 ↗出版商官网 ·
数据可用性

Formatting of funding sources: List funding sources in this standard way to facilitate compliance to funder's requirements:Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the U 模型摘要

List funding sources in this standard way to facilitate compliance to funder's requirements:Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States Institutes of Peace [grant number aaaa].

原文 ↗出版商官网 ·
许可与版权 Copyright

Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement. Authors will be asked to transfer copyright of their articles to the Japanese S…

原文 ↗出版商官网 ·
开放获取 Open access

Open access: For open access articles: Upon acceptance of an article, authors will be asked to complete an 'Exclusive License Agreement' (more information). Permitted third party reuse of open access articles is determined by the author's choice of user license. 模型摘要

Please visit our Open Access page for more information about open access publishing in this journal.

原文 ↗出版商官网 ·
同行评审 Peer review

This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…

原文 ↗出版商官网 ·
预印本 Preprint references

Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Springer Japan
出版国家或地区
JAPAN
出版语言
English
出版周期
Bimonthly
创刊年份
1995
ISSN
1341-321X
电子版 ISSN
1437-7780
学会 / 主办单位
Japanese Society of Chemotherapy
官方链接

常见问题

关于 Journal of Infection and Chemotherapy 的常见问题

Journal of Infection and Chemotherapy 是中科院几区期刊?

2025 年升级版分区表中,Journal of Infection and Chemotherapy 为医学 4区,小类 传染病学 / 药学 4 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。

Journal of Infection and Chemotherapy 的影响因子是多少?

LetPub 汇总的最新公布影响因子为 1.67,CiteScore 为 3.1,h-index 为 86。

Journal of Infection and Chemotherapy 的审稿周期多长?

按 2024年10月至2026年10月(近 24 个月)112 篇已发表文章登记的日期,投稿到接收的中位数为 91 天(四分位 67–115 天);投稿社区反馈的平均审稿速度为3–8 周;期刊官网公布的录用率为 21%。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Journal of Infection and Chemotherapy 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 74 位编委中,没有中国大陆学者;人数最多的国家是 日本(74 位)。统计按编委会页面列出的机构国家计,仅供参考。

Journal of Infection and Chemotherapy 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Journal of Infection and Chemotherapy 被 SCIE、Scopus 收录。期刊官网自述还被 PubMed 收录,该清单未与各数据库逐一核对。

Journal of Infection and Chemotherapy 是开放获取期刊吗?版面费多少?

Journal of Infection and Chemotherapy 为混合开放获取。选择开放获取发表时APC 约 2,650 美元。

来源与更新

本页事实来自 LetPub、出版商官网、OpenAlex;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。